Reversible visual disturbance due to cryptococcal uveitis in a non-HIV individual.
暂无分享,去创建一个
T. Kitaoka | K. Yanagihara | S. Kohno | H. Kakeya | Shigeki Nakamura | K. Izumikawa | Y. Mizuta | M. Seki | Yoshihiro Yamamoto | K. Fujimoto | K. Mishima
[1] A. Casadevall,et al. Susceptibility of Cryptococcus neoformans Biofilms to Antifungal Agents In Vitro , 2006, Antimicrobial Agents and Chemotherapy.
[2] K. Schmierer,et al. Diagnostic pitfalls in eosinophilic cryptococcal meningoencephalitis , 2003, The Lancet Neurology.
[3] M. Ghannoum,et al. Effects of Fluconazole Singly and in Combination with 5-Fluorocytosine or Amphotericin B in the Treatment of Cryptococcal Meningoencephalitis in an Intracranial Murine Model , 2002, Journal of chemotherapy.
[4] E. Gürsel,et al. Penetration of topical fluconazole into human aqueous humor. , 2001, Experimental eye research.
[5] D. Hospenthal,et al. Treatment of hydrocephalus secondary to cryptococcal meningitis by use of shunting. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] Michael H. Miller,et al. Comparison of fluconazole pharmacokinetics in serum, aqueous humor, vitreous humor, and cerebrospinal fluid following a single dose and at steady state. , 1998, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[7] R. Mugerwa,et al. Combination therapy with fluconazole and flucytosine for cryptococcal meningitis in Ugandan patients with AIDS. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[8] M. Ghannoum,et al. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Labora , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] R. Allen,et al. Cryptococcal ventricular-peritoneal shunt infection: clinical and epidemiological evaluation of two closely associated cases. , 1993 .
[10] R. Allen,et al. Cryptococcal Ventricular-Peritoneal Shunt Infection: Clinical and Epidemiological Evaluation of Two Closely Associated Cases , 1993, Infection Control & Hospital Epidemiology.
[11] S. Elner,et al. Cryptococcal endophthalmitis: case report and review. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] D. Denning,et al. Endophthalmitis in a patient with disseminated cryptococcosis and AIDS who was treated with itraconazole. , 1991, Reviews of infectious diseases.
[13] L. M. Tang,et al. Ventriculoperitoneal shunt in cryptococcal meningitis with hydrocephalus. , 1990, Surgical neurology.
[14] A. Friedman,et al. Successful treatment of cryptococcal ventriculoatrial shunt infection with systemic therapy alone. , 1988, Neurosurgery.
[15] M. Salcman,et al. Ventriculoatrial shunt infection due to Cryptococcus neoformans: an ultrastructural and quantitative microbiological study. , 1986, Neurosurgery.
[16] C. Crum,et al. Cryptococcal peritonitis complicating a ventriculoperitoneal shunt in unsuspected cryptococcal meningitis. , 1981, Human pathology.